Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections

about

Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections

Item

http://www.wikidata.org/entity/Q35574202

description

1986 nî lūn-bûn

@nan

1986年の論文

@ja

1986年論文

@yue

1986年論文

@zh-hant

1986年論文

@zh-hk

1986年論文

@zh-mo

1986年論文

@zh-tw

1986年论文

@wuu

1986年论文

@zh

1986年论文

@zh-cn

name

Double-blind, prospective, mul ...... rious gram-negative infections

@ast

Double-blind, prospective, mul ...... rious gram-negative infections

@en

type

Item

label

Double-blind, prospective, mul ...... rious gram-negative infections

@ast

Double-blind, prospective, mul ...... rious gram-negative infections

@en

prefLabel

Double-blind, prospective, mul ...... rious gram-negative infections

@ast

Double-blind, prospective, mul ...... rious gram-negative infections

@en

P1476

Double-blind, prospective, mul ...... rious gram-negative infections

@en

P2093

Anthony WC

http://www.w3.org/2001/XMLSchema#string

Caplan ES

http://www.w3.org/2001/XMLSchema#string

Drusano GL

http://www.w3.org/2001/XMLSchema#string

Henson A

http://www.w3.org/2001/XMLSchema#string

Joshi M

http://www.w3.org/2001/XMLSchema#string

Standiford HC

http://www.w3.org/2001/XMLSchema#string

Tenney JH

http://www.w3.org/2001/XMLSchema#string

Warren JW

http://www.w3.org/2001/XMLSchema#string

P2860

API system: a multitube micromethod for identification of Enterobacteriaceae

Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.

Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.

Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy.

Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms.

Comparative antipseudomonal activity of some newer beta-lactam agents.

The new beta-lactamase-stable cephalosporins.

Oral or intravenous trimethoprim-sulfamethoxazole therapy for shigellosis.

Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.

The combination of pivmecillinam and pivampicillin in the treatment of acute enteric fever.

P304

90-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.30.1.90

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1986-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19632049

http://www.w3.org/2001/XMLSchema#string

P698

3530128

http://www.w3.org/2001/XMLSchema#string

P921

Gram-negative bacteria

P932

176442

http://www.w3.org/2001/XMLSchema#string